Results 31 to 40 of about 679,279 (310)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2

Mathematical Biosciences and Engineering, 2021
<abstract> <p>COVID-19 is increasingly affecting human health and global economy. Understanding the fundamental mechanisms of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is highly demanded to develop treatments for COVID-19.
Wenhan Guo, Yixin Xie, Alan E Lopez-Hernandez, Shengjie Sun, Lin Li   +4 more
openaire   +3 more sources

Children and SARS-CoV-2 [PDF]

Cell Host & Microbe, 2021
A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss ...
Bogunovic, Dusan, Merad, Miriam
openaire   +2 more sources

Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. [PDF]

, 2006
We systematically reviewed the current understanding of human population immunity against SARS-CoV in different groups, settings and geography. Our meta-analysis, which included all identified studies except those on wild animal handlers, yielded an ...
Donnelly, CA, Hedley, AJ, Ferguson, NM, Ho, LM, Lam, T-H, Ghani, AC, Anderson, RM, Lam, TH, Ho, L-M, Riley, S, Leung, GM, Fraser, C, Lim, WW   +12 more
core   +1 more source

Anti-SARS-CoV-2 S-RBD IgG antibody and anti-SARS-CoV-2 NAb levels.

, 2023
Anti-SARS-CoV-2 S-RBD IgG antibody and anti-SARS-CoV-2 NAb levels.
Lugyanti Sukrisman (4808703), Rachelle Betsy (14249303), Andhika Rachman (7827761), Anna Mira Lubis (14700919), Dimas Priantono (14249297), Samuel Juanputra (14249306), Findy Prasetyawati (14700925), Bayu Bijaksana Rumondor (14249300), Wulyo Rajabto (14700913), Anggraini Iriani (14249294), Nadia Ayu Mulansari (14700916), Rahmat Cahyanur (14700922)   +11 more
core   +1 more source

SARS-CoV-2 variants.

, 2022
SARS-CoV-2 variants.
Ghadeer A. R. Y. Suaifan (14232237), Moyad Shahwan (9562585), Mayadah B. Shehadeh (14232243), Fahid Abu Jbara (14232249), Ala’ M. Abu-Odeh (14232240), Rula M. Darwish (14232246)   +5 more
core   +2 more sources

Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities

Thoracic Cancer, 2021
Several studies have highlighted that cancer patients tend to be more susceptible to develop severe infection and to die from COVID‐19. Certain medical conditions such as immunosuppression, presence of comorbidities, and underlying pulmonary damage are ...
Ana Emília Goulart Lemos, Gabriela Ribeiro Silva, Etel Rodrigues Pereira Gimba, Aline da Rocha Matos   +3 more
doaj   +1 more source

Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent Fc gamma R Pathway [PDF]

, 2011
Copyright © 2011, American Society for Microbiology. All Rights Reserved.Public health measures successfully contained outbreaks of the severe acute respiratory syndrome coronavirus (SARS-CoV) infection.
Cheung, Chung y, Marc Daëron, Li, PH, Altmeyer, Ralf, Ping H. Li, Leung, Hiu L, Escriou, N, Dutry, Isabelle, Ming S. Yip, Kien, Francois, Cheung, CY, Dutry, I, Li, Ping H, Benoît Callendret, Nal, B, Chung Y. Cheung, Altmeyer, R, Peiris, J S Malik, Ralf Altmeyer, Bruzzone, R, Jaume, Martial, Martial Jaume, Nicolas Escriou, Callendret, B, Isabelle Dutry, Escriou, Nicolas, Beatrice Nal, Kien, F, Francois Kien, Jaume, M, Yip, MS, Bruzzone, Roberto, J. S. Malik Peiris, Yip, Ming S, Daëron, Marc, Roberto Bruzzone, Hiu L. Leung, Leung, HL, Peiris, JSM, Nal, Beatrice, Daeron, M   +40 more
core   +1 more source

Reporte nº17 – Provincia de Córdoba – 19 de marzo de 2021. Consorcio interinstitucional para la Secuenciación del genoma y estudios genómicos de SARS-COV-2 (Proyecto PAIS) [PDF]

, 2021
Fil: Consorcio Argentino de Genómica de SARS-CoV-2; Argentina.Fil: Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. Instituto de Virología Dr. José María Vanella; Argentina.Fil: Gobierno de la Provincia de Córdoba.
Gobierno de la Provincia de Córdoba. Ministerio de Salud. Laboratorio Central, Consorcio Argentino de Genómica de SARS-CoV-2, Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. Instituto de Virología Dr. José María Vanella   +2 more
core  

The SARS-coronavirus-host interactome [PDF]

, 2011
Coronaviruses (CoVs) are important human and animal pathogens that induce fatal respiratory, gastrointestinal and neurological disease. The outbreak of the severe acute respiratory syndrome (SARS) in 2002/2003 has demonstrated human vulnerability to ...
Brunn, Albrecht von, Steffen, Imke, Kögl, Manfred, Schwegmann-Wessels, Christel, Pumpor, Ksenia, Müller, Marcel A., Herzog, Petra, Kuri, Thomas, Ditt, Vanessa, Weber, Friedemann, Schwarz, Frank, Pfefferle, Susanne, Schöpf, Julia, Kallies, Stefan, Herrler, Georg, Carbajo-Lozoya, Javier, Zimmer, Ralf, Hilgenfeld, Rolf, Friedel, Caroline C., Dall'Armi, Ekatarina von, Drosten, Christian, Niemeyer, Daniela, Thiel, Volker, Züst, Roland, Stellberger, Thorsten, Thiel, Heinz-Jürgen, Pöhlmann, Stefan, Haas, Juergen G.   +27 more
core   +1 more source

Cardiovascular disease in SARS‐CoV‐2 infection

Clinical & Translational Immunology, 2021
Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease.
Kei Sato, Jane E Sinclair, Habib Sadeghirad, John F Fraser, Kirsty R Short, Arutha Kulasinghe   +5 more
doaj   +1 more source